|
1
|
Semple RK, Chatterjee VK and O'Rahilly S:
PPAR gamma and human metabolic disease. J Clin Invest. 116:581–589.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forman BM, Tontonoz P, Chen J, Brun RP,
Spiegelman BM and Evans RM: 15-Deoxy-delta 12, 14-prostaglandin J2
is a ligand for the adipocyte determination factor PPAR γ. Cell.
83:803–812. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kliewer SA, Lenhard JM, Willson TM, Patel
I, Morris DC and Lehmann JM: A prostaglandin J2 metabolite binds
peroxisome proliferator-activated receptor γ and promotes adipocyte
differentiation. Cell. 83:813–819. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yue Tl TL, Chen J, Bao W, Narayanan PK,
Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, et al: In
vivo myocardial protection from ischemia/reperfusion injury by the
peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
Circulation. 104:2588–2594. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shimazu T, Inoue I, Araki N, Asano Y,
Sawada M, Furuya D, Nagoya H and Greenberg JH: A peroxisome
proliferator-activated receptor-γ agonist reduces infarct size in
transient but not in permanent ischemia. Stroke. 36:353–359. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sundararajan S, Gamboa JL, Victor NA,
Wanderi EW, Lust WD and Landreth GE: Peroxisome
proliferator-activated receptor-gamma ligands reduce inflammation
and infarction size in transient focal ischemia. Neuroscience.
130:685–696. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin TN, Cheung WM, Wu JS, Chen JJ, Lin H,
Chen JJ, Liou JY, Shyue SK and Wu KK: 15d-prostaglandin J2 protects
brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc
Biol. 26:481–487. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen ST, Hsu CY, Hogan EL, Maricq H and
Balentine JD: A model of focal ischemic stroke in the rat:
Reproducible extensive cortical infarction. Stroke. 17:738–743.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin TN, He YY, Wu G, Khan M and Hsu CY:
Effect of brain edema on infarct volume in a focal cerebral
ischemia model in rats. Stroke. 24:117–121. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai YS, Kim HJ, Takahashi N, Kim HS,
Hagaman JR, Kim JK and Maeda N: Hypertension and abnormal fat
distribution but not insulin resistance in mice with P465L
PPARgamma. J Clin Invest. 114:240–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu X, Rea HC, Wiktorowicz JE and
Perez-Polo JR: Proteomic analysis of hypoxia/ischemia-induced
alteration of cortical development and dopamine neurotransmission
in neonatal rat. J Proteome Res. 5:2396–2404. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu K, Mori S, Takahashi HK, Tomono Y,
Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, et al:
Anti-high mobility group box 1 monoclonal antibody ameliorates
brain infarction induced by transient ischemia in rats. FASEB J.
21:3904–3916. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liou JY, Ghelani D, Yeh S and Wu KK:
Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell
apoptosis by suppressing 14-3-3epsilon. Cancer Res. 67:3185–3191.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawamoto Y, Akiguchi I, Tomimoto H,
Shirakashi Y, Honjo Y and Budka H: Upregulated expression of 14-3-3
proteins in astrocytes from human cerebrovascular ischemic lesions.
Stroke. 37:830–835. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Umahara T, Uchihara T, Tsuchiya K,
Nakamura A and Iwamoto T: Intranuclear localization and
isoform-dependent translocation of 14-3-3 proteins in human brain
with infarction. J Neurol Sci. 260:159–166. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lehmann JM, Moore LB, Smith-Oliver TA,
Wilkison WO, Willson TM and Kliewer SA: An antidiabetic
thiazolidinedione is a high affinity ligand for peroxisome
proliferator-activated receptor γ (PPAR γ). J Biol Chem.
270:12953–12956. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ricote M, Li AC, Willson TM, Kelly CJ and
Glass CK: The peroxisome proliferator-activated receptor-γ is a
negative regulator of macrophage activation. Nature. 391:79–82.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang C, Ting AT and Seed B: PPAR-γ
agonists inhibit production of monocyte inflammatory cytokines.
Nature. 391:82–86. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chawla A, Barak Y, Nagy L, Liao D,
Tontonoz P and Evans RM: PPAR-γ dependent and independent effects
on macrophage-gene expression in lipid metabolism and inflammation.
Nat Med. 7:48–52. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Welch JS, Ricote M, Akiyama TE, Gonzalez
FJ and Glass CK: PPARgamma and PPARdelta negatively regulate
specific subsets of lipopolysaccharide and IFN-γ target genes in
macrophages. Proc Natl Acad Sci USA. 100:pp. 6712–6717. 2003;
View Article : Google Scholar : PubMed/NCBI
|
